Lawrence D Piro

Title: Innovations by Lawrence D Piro

Introduction

Lawrence D Piro is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medicine, particularly in the treatment of histiocytosis and cancerous B cells. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is for a treatment involving 2-halo-2'-deoxyadenosine for histiocytosis. This improved method aims to treat Class I histiocytosis, including Langerhans cell histiocytosis, by administering a therapeutically effective amount of 2-halo-2'-deoxyadenosine to a host mammal, such as a human patient. The recommended dosage is about 0.5 to 0.9 mg/kg of body weight over a course of about 5 to 9 days for up to two courses. Another significant patent focuses on cancerous B cell treatment using substituted nucleoside derivatives. This process involves killing cancerous B cells, particularly those associated with chronic lymphocytic leukemia (CLL). The method enhances the death of these cancer cells through a combination of immune response-enhancing agents and cytotoxic drugs.

Career Highlights

Lawrence D Piro has worked with prestigious organizations, including The Scripps Research Institute. His experience in these institutions has allowed him to develop innovative treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Alan Saven and Michael G Goodman. Their collaboration has likely contributed to the advancements in the research and development of his patented treatments.

Conclusion

Lawrence D Piro's contributions to medical innovation through his patents demonstrate his commitment to improving healthcare. His work in treating histiocytosis and cancerous B cells showcases the potential of scientific research to create effective therapies.